PPLPHARMA
₹188.38-1.26 (-0.66%)
Quarterly ResultsProfit & LossBalance SheetCash Flow
Key Insights
POSITIVE
- Net Sales increased significantly in the latest quarter (202503) to ₹2754.07 crore from ₹2204.22 crore, showing strong growth.
- Operating margin improved dramatically to 7.79% in Q3 2025, a recovery from previous lows, indicating better cost management.
- Net profit rebounded to ₹153.5 crore in Q3 2025, compared to a minimal profit of ₹3.68 crore in Q2 2024.
NEGATIVE
- Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
- Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
- Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
| Field | Trend | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,958.57 | 2,552.36 | 1,951.14 | 2,241.75 | 2,204.22 | 2,754.07 | 1,933.71 | 2,043.72 | |
| Expenses | 1,982.40 | 2,332.78 | 2,038.16 | 2,200 | 2,166.60 | 2,539.52 | 2,110.44 | 2,170.29 | |
| Operating Profit | -23.83 | 219.58 | -87.02 | 41.75 | 37.62 | 214.55 | -176.73 | -126.57 | |
| Other Income | 61.51 | 26.38 | 19.54 | 61.11 | 12.13 | 42.03 | 58.40 | 65.60 | |
| Interest | 105.88 | 114.22 | 106.96 | 107.64 | 103.31 | 103.68 | 86.15 | 82.42 | |
| Depreciation | 186.32 | 196.13 | 184.55 | 192.22 | 196.81 | 242.76 | 197.28 | 202.84 | |
| Profit Before Tax | 19.36 | 227.48 | -45.08 | 120.12 | 66.80 | 272.80 | -79.02 | -46.18 | |
| Tax | 9.25 | 126.21 | 43.56 | 97.53 | 63.12 | 119.30 | 2.68 | 53.04 | |
| Net Profit | 10.11 | 101.27 | -88.64 | 22.59 | 3.68 | 153.50 | -81.70 | -99.22 | |
| EPS in Rs | 0.08 | 0.77 | -0.67 | 0.17 | 0.03 | 1.16 | -0.62 | -0.75 |